Functionally defined therapeutic targets in diffuse intrinsic pontine glioma

Grasso, Catherine S, Tang, Yujie, Truffaux, Nathalene, Berlow, Noah E, Liu, Lining, Debily, Marie-Anne, Quist, Michael J, Davis, Lara E +32 more·2015·Nature Medicine

DOI 10.1038/nm.3855

Cited by (686)

Items 201–300 of 686

The transcription factor Olig2 is important for the biology of diffuse intrinsic pontine gliomas
Jane Anderson, Ranjithmenon Muraleedharan, Nicole Oatman, A. Klotter, Satarupa Sengupta, R. Waclaw, Jian-Qiang Wu, R. Drissi, L. Miles, E. Raabe et al. · 2017 · Neuro-Oncology
International experience in the development of patient-derived xenograft models of diffuse intrinsic pontine glioma
Maria Tsoli, Han M. Shen, Chelsea Mayoh, Laura Franshaw, Anahid Ehteda, Dannielle H. Upton, Diana M. Carvalho, Maria Vinci, Michaël Hananja Meel, Dannis Gilbert van Vuurden et al. · 2018 · Journal of Neuro-Oncology
Structural variants shape driver combinations and outcomes in pediatric high-grade glioma
Frank P. B. Dubois, Ofer Shapira, Noah F. Greenwald, Travis Ian Zack, Jeremiah A. Wala, Jessica W. Tsai, Alexander Crane, Audrey Baguette, Djihad Hadjadj, Ashot S. Harutyunyan et al. · 2022 · Nature Cancer
Oncohistones: Exposing the nuances and vulnerabilities of epigenetic regulation
Michelle M. Mitchener, Tom W. Muir · 2022 · Molecular Cell
Culture methods of diffuse intrinsic pontine glioma cells determine response to targeted therapies
Michaël Hananja Meel, A.Charlotte P. Sewing, Piotr Waranecki, Dennis Serge Metselaar, Laurine E. Wedekind, Jan Köster, Dannis Gilbert van Vuurden, Gertjan J.L. Kaspers, Esther Hulleman · 2017 · Experimental Cell Research
IL-13 receptors as possible therapeutic targets in diffuse intrinsic pontine glioma
Noah Berlow, Matthew N. Svalina, Michael J. Quist, Teagan P. Settelmeyer, Viktor A. Zherebitskiy, Mari Kogiso, Lin Qi, Yuchen Du, Cynthia E Hawkins, Esther Hulleman et al. · 2018 · PLoS ONE
A phase I study of panobinostat in pediatric patients with refractory solid tumors, including CNS tumors
Paul Wood, Robyn Strong, Grant A. McArthur, Michael Michael, Elizabeth M. Algar, Andrea M. Muscat, Lin Rigby, Melissa Ferguson, David M. Ashley · 2018 · Cancer Chemotherapy and Pharmacology
In Vivo and Ex Vivo Pediatric Brain Tumor Models: An Overview
Zhiqin Li, Sigrid A. Langhans · 2021 · Frontiers in Oncology
Lactate-dependent transcriptional regulation controls mammalian eye morphogenesis
Nozomu Takata, Jason M. Miska, Marc A. Morgan, Priyam A. Patel, Leah K. Billingham, Neha Joshi, Matthew John Schipma, Zachary J. Dumar, Nikita Joshi, Alexander V. Misharin et al. · 2023 · Nature Communications
The histone demethylase KDM6B in the medial prefrontal cortex epigenetically regulates cocaine reward memory
Yu-Xiang Zhang, Rita C. Akumuo, Rodrigo A. España, Chunxia Yan, Wen‐Jun Gao, Yan-Chun Li · 2018 · Neuropharmacology
Hepatoblastoma: A Need for Cell Lines and Tissue Banks to Develop Targeted Drug Therapies
Rishi Raj Rikhi, Kimberlee K. Spady, Ruth Irene Hoffman, Michael S. Bateman, Max Bateman, Lisa Easom Howard · 2016 · Frontiers in Pediatrics
Reversal of cancer gene expression identifies repurposed drugs for diffuse intrinsic pontine glioma
Guisheng Zhao, Patrick A. Newbury, Yukitomo Ishi, Eugene Chekalin, Billy Zeng, Benjamin Scott Glicksberg, Anita Wen, Shreya Paithankar, Takahiro Sasaki, Amreena Suri et al. · 2022 · Acta Neuropathologica Communications
Targeting diffuse midline gliomas: The promise of focused ultrasound-mediated blood-brain barrier opening
Payton J. Martinez, Adam L. Green, Mark Andrew Borden · 2023 · Journal of Controlled Release
Pediatric Brain Tumors: Current Knowledge and Therapeutic Opportunities
John W. Glod, Gilbert J. Rahme, Harpreet Kaur, Eric H. Raabe, Eugene I. Hwang, Mark A. Israel · 2016 · Journal of Pediatric Hematology/Oncology
Molecular pathogenesis and therapeutic implications in pediatric high-grade gliomas
Tareq Adnan Juratli, Nan Qin, Daniel P. Cahill, Mariella G. Filbin · 2017 · Pharmacology & Therapeutics
Therapeutic avenues for targeting treatment challenges of diffuse midline gliomas
Aleeha Noon, Stefanie Galbán · 2023 · Neoplasia
Polo-like Kinase 1 as a potential therapeutic target in Diffuse Intrinsic Pontine Glioma
Vladimir M. Amani, Eric W. Prince, Irina N. Alimova, Ilango Balakrishnan, Diane K. Birks, Andrew M. Donson, Peter S. Harris, Jean M. Mulcahy Levy, Michael H. Handler, Nicholas K. Foreman et al. · 2016 · BMC Cancer
Pediatric high-grade glioma resources from the Children’s Brain Tumor Tissue Consortium
Heba Ijaz, Mateusz Koptyra, Krutika Satish Gaonkar, Jo Lynne Rokita, Valérie Baubet, Lamiya Tauhid, Yuankun Zhu, Miguel Brown, Gonzalo López, Bo Zhang et al. · 2019 · Neuro-Oncology
Hemispherical Pediatric High-Grade Glioma: Molecular Basis and Therapeutic Opportunities
Santiago Haase, Fernando M. Núñez, Jessica C. Gauss, Sarah Thompson, Emily K. Brumley, Pedro Ricardo Lowenstein, Maria Graciela Castro · 2020 · International Journal of Molecular Sciences
Induction of Synthetic Lethality by Activation of Mitochondrial ClpP and Inhibition of HDAC1/2 in Glioblastoma
Trang T.T. Nguyen, Enyuan Shang, Salveena Schiffgens, Consuelo Torrini, Chang Shu, Hasan Orhan Akman, Varun V. Prabhu, Joshua E. Allen, Mike-Andrew Westhoff, Georg Karpel-Massler et al. · 2022 · Clinical Cancer Research
Multi-omics and pharmacological characterization of patient-derived glioma cell lines
Min Wu, Tingting Wang, Nan Ji, Ting Lu, Ran Yuan, Lingxiang Wu, Junxia Zhang, Mengyuan Li, Penghui Cao, Jiarui Zhao et al. · 2024 · Nature Communications
Shared ACVR1 mutations in FOP and DIPG: Opportunities and challenges in extending biological and clinical implications across rare diseases
Harry J. Han, Payal Jain, Adam Cain Resnick · 2017 · Bone
Extending the Neuroanatomic Territory of Diffuse Midline Glioma, K27M Mutant: Pineal Region Origin
Andrea Gilbert, Wafik Tharwat Zaky, Murat Gökden, Christine E. Fuller, Eylem Öcal, Norman E. Leeds, Gregory N. Fuller · 2017 · Pediatric Neurosurgery
Potent anti-tumor efficacy of palbociclib in treatment-naïve H3.3K27M-mutant diffuse intrinsic pontine glioma
Yu Sun, Ye Sun, Kun Huang Yan, Zhuxuan Li, Cheng Xu, Yibo Geng, Changcun Pan, Xin Chen, Liwei Zhang, Qiaoran Xi · 2019 · EBioMedicine
Safety and efficacy of brainstem biopsy in children and young adults
David S. Hersh, Rahul Kumar, Kenneth A. Moore, Luke G. F. Smith, Christopher L. Tinkle, Jason Chiang, Zoltan J Patay, Amar J. Gajjar, Asim F. Choudhri, Jorge A. Lee-Diaz et al. · 2020 · Journal of Neurosurgery Pediatrics
Hypofractionated Radiation Therapy For Diffuse Intrinsic Pontine Glioma: A Noninferiority Randomized Study Including 253 Children
Mohamed S. Zaghloul, Azza Mohamed Nasr, Marwan Tolba, Amal Refaat, Ayda A. Youssef, Amal Mosaab, Abdelrhman Enayet, Omar Arafa, Eslam Maher, Eman Eldebawy · 2022 · International Journal of Radiation Oncology*Biology*Physics
Genomic profiling and prognostic factors of H3 K27M ‐mutant spinal cord diffuse glioma
Ruichao Chai, Hao Yan, Song‐Yuan An, Bo Pang, Huiyuan Chen, Quanhua Mu, Kenan Zhang, Yao-Wu Zhang, Yu‐Qing Liu, Xing Liu et al. · 2023 · Brain Pathology
MRI comparative study of diffuse midline glioma, H3 K27-altered and glioma in the midline without H3 K27-altered
Jiping Zhao, Xuejun Liu, Haozhi Lin, Chunxiao Cui, Ying-jie Yue, Song Gao, Hong-zhang Xu · 2022 · BMC Neurology
Diffuse midline glioma invasion and metastasis rely on cell-autonomous signaling
Marco Bruschi, Lilia Midjek, Yassine Ajlil, Stéphanie Vairy, Manon Lancien, Samia Ghermaoui, Thomas Kergrohen, Maïté Verreault, Ahmed Idbaïh, Carlos Alberto Oliveira de Biagi et al. · 2023 · Neuro-Oncology
Opportunities and challenges for patient-derived models of brain tumors in functional precision medicine
Breanna Mann, Nichole Artz, Rami Darawsheh, David E. Kram, Shawn Hingtgen, Andrew Satterlee · 2025 · npj Precision Oncology
Preclinical evaluation of convection-enhanced delivery of liposomal doxorubicin to treat pediatric diffuse intrinsic pontine glioma and thalamic high-grade glioma
A. Charlotte P. Sewing, Tonny Lagerweij, Dannis Gilbert van Vuurden, Michaël Hananja Meel, Susanna J.E. Veringa, Angel Montero Carcaboso, Pieter Jaap Gaillard, William Peter Vandertop, Pieter Wesseling, David P. Noske et al. · 2017 · Journal of Neurosurgery Pediatrics
Characterization of the Blood–Brain Barrier Integrity and the Brain Transport of SN-38 in an Orthotopic Xenograft Rat Model of Diffuse Intrinsic Pontine Glioma
Catarina Chaves, Xavier Declèves, Méryam Taghi, Marie‐Claude Menet, Joëlle Lacombe, Pascale Varlet, Nagore Gené Olaciregui, Angel Montero Carcaboso, Salvatore Cisternino · 2020 · Pharmaceutics
Emerging Advances in Combinatorial Treatments of Epigenetically Altered Pediatric High-Grade H3K27M Gliomas
Katarzyna B. Leszczyńska, Chinchu Jayaprakash, Bozena Kaminska, Jakub Mieczkowski · 2021 · Frontiers in Genetics
Imaging diagnosis and treatment selection for brain tumors in the era of molecular therapeutics
Saivenkat H. Vagvala, Jeffrey P. Guenette, Camilo E. Jaimes, Raymond Y. Huang · 2022 · Cancer Imaging
Impact of H3K27 Demethylase Inhibitor GSKJ4 on NSCLC Cells Alone and in Combination with Metformin
HIKARU WATARAI, Masashi Okada, Kenta Kuramoto, HIROYUKI TAKEDA, TAKEDA SAKAKI, Shuhei Suzuki, Shizuka Seino, Hiroyuki Oizumi, Mitsuaki Sadahiro, Chifumi Kitanaka · 2016 · Anticancer Research
Combined use of CDK4/6 and mTOR inhibitors induce synergistic growth arrest of diffuse intrinsic pontine glioma cells via mutual downregulation of mTORC1 activity
Daniel J. Asby, Clare L. Killick-Cole, Lisa J. Boulter, William Singleton, Claire Asby, Marcella J. Wyatt, Neil U. Barua, Alison S. Bienemann, Steven Gill · 2018 · Cancer Management and Research
Bivalent Genes Targeting of Glioma Heterogeneity and Plasticity
Mariam Markouli, Dimitrios Strepkos, Kostas A. Papavassiliou, Athanasios G. Papavassiliou, Christina Piperi · 2021 · International Journal of Molecular Sciences
Antisense oligonucleotide therapy for H3.3K27M diffuse midline glioma
Qian Zhang, Lucia Yang, Ying Hsiu Liu, John Erby Wilkinson, Adrian R. Krainer · 2023 · Science Translational Medicine
Effective Drug Delivery in Diffuse Intrinsic Pontine Glioma: A Theoretical Model to Identify Potential Candidates
Fatma E. El‐Khouly, Dannis Gilbert van Vuurden, Thom Stroink, Esther Hulleman, Gertjan J.L. Kaspers, N. Harry Hendrikse, Sophie E. M. Veldhuijzen van Zanten · 2017 · Frontiers in Oncology
Celastrol-induced degradation of FANCD2 sensitizes pediatric high-grade gliomas to the DNA-crosslinking agent carboplatin
Dennis Serge Metselaar, Michaël Hananja Meel, Bente Benedict, Piotr Waranecki, Jan Köster, Gertjan J.L. Kaspers, Esther Hulleman · 2019 · EBioMedicine
Epigenetic alterations in glioblastomas: Diagnostic, prognostic and therapeutic relevance
Liliana Montella, Mariella Cuomo, Nunzio Del Gaudio, Michela Buonaiuto, Davide Costabile, Roberta Visconti, Teodolinda Di Risi, Roberta Vinciguerra, Federica Trio, Sara Ferraro et al. · 2022 · International Journal of Cancer
Common molecular features of H3K27M DMGs and PFA ependymomas map to hindbrain developmental pathways
Matthew J Pun, Drew W. Pratt, Patricia R. Nano, Piyush K. Joshi, Li Jiang, Bernhard Englinger, Arvind U.K. Rao, Marcin P. Cieslik, Arul M. Chinnaiyan, Kenneth Aldape et al. · 2023 · Acta Neuropathologica Communications
Epigenetic blockade of neoplastic transformation by bromodomain and extra-terminal (BET) domain protein inhibitor JQ-1
Chengyue Zhang, Zheng‐Yuan Su, Ling Wang, Limin Shu, Yuqing Yang, Yue Guo, Douglas Pung, C. Bountra, Ah‐Ng Tony Kong · 2016 · Biochemical Pharmacology
High expression of MKP1/DUSP1 counteracts glioma stem cell activity and mediates HDAC inhibitor response
Olatz Arrizabalaga, Leire Moreno‐Cugnon, Jaione Auzmendi-Iriarte, Paula Aldaz, Inmaculada Ibañez de Cáceres, Laura Garros-Regulez, Verónica Moncho-Amor, Sergio Torres-Bayona, Olga Pernía, Laura Pintado‐Berninches et al. · 2017 · Oncogenesis
Chaetocin-mediated SUV39H1 inhibition targets stemness and oncogenic networks of diffuse midline gliomas and synergizes with ONC201
Dazhuan Eric Xin, Yunfei Liao, Rohit Rao, Sean Ogurek, Soma Sengupta, Mei Xin, Arman Esshaghi Bayat, William L. Seibel, Richard T. Graham, Carl Johannes Koschmann et al. · 2023 · Neuro-Oncology
Current status and advances to improving drug delivery in diffuse intrinsic pontine glioma
Lauren Arms, Ryan J. Duchatel, Evangeline R. Jackson, Pedro Garcia Sobrinho, Matthew D. Dun, Susan Hua · 2024 · Journal of Controlled Release
Pediatric thalamic glioma with H3F3A K27M mutation, which was detected before and after malignant transformation: a case report
Kenichi Ishibashi, Takeshi Inoue, Hiroko Fukushima, Yusuke Watanabe, Yoshiyasu Iwai, Hiroaki Sakamoto, Kai Yamasaki, Jyunichi Hara, Tomoko Shofuda, Daiksuke Kanematsu et al. · 2016 · Child s Nervous System
Patient-Derived Orthotopic Xenograft (PDOX) Mouse Models of Primary and Recurrent Meningioma
Huiyuan Zhang, Lin Qi, Yuchen Du, Lei Frank Huang, Frank Braun, Mari Kogiso, Yanling Zhao, Can Li, Holly Lindsay, Sibo Zhao et al. · 2020 · Cancers
Panobinostat penetrates the blood–brain barrier and achieves effective brain concentrations in a murine model
Morgan J. Homan, Andrea T. Franson, Karthik Ravi, Holly J. Roberts, Manjunath P. Pai, Cai Liu, Miao He, Aleksas Matvekas, Carl Johannes Koschmann, Bernard Lawrence Marini · 2021 · Cancer Chemotherapy and Pharmacology
Discovering new PI3Kα inhibitors with a strategy of combining ligand-based and structure-based virtual screening
Miao Yu, Qiong Gu, Jun Xu · 2018 · Journal of Computer-Aided Molecular Design
Targeting Epigenetic Pathways in the Treatment of Pediatric Diffuse (High Grade) Gliomas
Magimairajan Vanan, D. Alan Underhill, David D. Eisenstat · 2017 · Neurotherapeutics
Epigenetic Regulation of Telomere Maintenance for Therapeutic Interventions in Gliomas
Elisabeth Naderlinger, Klaus Holzmann · 2017 · Genes
Paediatric Gliomas: BRAF and Histone H3 as Biomarkers, Therapy and Perspective of Liquid Biopsies
Jean Yin Tan, Ipalawattage Vindya Stephnie Wijesinghe, Muhamad Noor Alfarizal Kamarudin, Ishwar S. Parhar · 2021 · Cancers
Design considerations of an IL13Rα2 antibody–drug conjugate for diffuse intrinsic pontine glioma
Xiaolei Lian, Dina Kats, Samuel V. Rasmussen, Leah R. Martin, Anju Karki, Charles Keller, Noah Berlow · 2021 · Acta Neuropathologica Communications
Polycomb repressive complex 2 in the driver’s seat of childhood and young adult brain tumours
Brian Krug, Ashot S. Harutyunyan, Shriya Deshmukh, Nada Jabado · 2021 · Trends in Cell Biology
Histone Mutations in Cancer
Kosuke Funato, Viviane S. Tabar · 2017 · Annual Review of Cancer Biology
Biomarker-Based PET Imaging of Diffuse Intrinsic Pontine Glioma in Mouse Models
Susanne Kossatz, Brandon D. Carney, Melanie E. Schweitzer, Giuseppe Carlucci, Vesselin Z. Miloushev, Uday Bhanu Maachani, Prajwal Rajappa, Kayvan R. Keshari, David J. Pisapia, Wolfgang Weber et al. · 2017 · Cancer Research
GSK-J4 induces cell cycle arrest and apoptosis via ER stress and the synergism between GSK-J4 and decitabine in acute myeloid leukemia KG-1a cells
Xuan Chu, Liang Zhong, Lihua Yu, Ling Xiong, Jian Li, Wenran Dan, Jiao Ye, Chen Liu, Xu Wei Luo, Beizhong Liu · 2020 · Cancer Cell International
Evaluation of an EZH2 inhibitor in patient-derived orthotopic xenograft models of pediatric brain tumors alone and in combination with chemo- and radiation therapies
Lin Qi, Holly Lindsay, Mari Kogiso, Yuchen Du, Frank Braun, Huiyuan Zhang, Lei Ming Guo, Sibo Zhao, Sarah Garrett Injac, Patricia Ann Baxter et al. · 2021 · Laboratory Investigation
Multi-focal sequencing of a diffuse intrinsic pontine glioma establishes PTEN loss as an early event
Carl Johannes Koschmann, Zishaan Farooqui, Katayoon Kasaian, Xuhong Cao, Daniel B. Zamler, Stefanie Stallard, Sriram Venneti, Shawn L. Hervey‐Jumper, Hugh J. L. Garton, Karin M. Muraszko et al. · 2017 · npj Precision Oncology
Hypoxic Environment and Paired Hierarchical 3D and 2D Models of Pediatric H3.3-Mutated Gliomas Recreate the Patient Tumor Complexity
Anne-Florence Blandin, Aurélie Durand, Marie Litzler, Aurélien Tripp, Éric Guérin, Elisa Ruhland, Adeline Knittel-Obrecht, Céline Keime, Quentin Fuchs, Damien Reita et al. · 2019 · Cancers
PET, image-guided HDAC inhibition of pediatric diffuse midline glioma improves survival in murine models
Umberto Tosi, Harikrishna Kommidi, Oluwaseyi O. Adeuyan, Hua Guo, Uday Bhanu Maachani, Nandi Chen, Taojunfeng Su, Guoan Zhang, David J. Pisapia, Nadia Dahmane et al. · 2020 · Science Advances
CAR T-cells to treat brain tumors
Grace Guzman, Karolina Pellot, Megan R. Reed, Analiz Rodriguez · 2023 · Brain Research Bulletin
Targeting SWI/SNF ATPases in H3.3K27M diffuse intrinsic pontine gliomas
Mateus Mota, Stefan R. Sweha, Matthew J Pun, Siva Kumar Natarajan, Yujie Ding, Chan Chung, Debra Hawes, Fusheng Yang, Alexander Russell Judkins, Susanta Samajdar et al. · 2023 · Proceedings of the National Academy of Sciences
Second re-irradiation for DIPG progression, re-considering “old strategies” with new approaches
Andrés Morales La Madrid, Vicente Santa‐María, Ofelia Cruz Martinez, Jaume Mora, Patricia Puerta, Antonio Guillén Quesada, Mariona Suñol Capella, Carmen de Torres Gomez‐Pallete, Álvaro Lassaletta, Normand Laperrière et al. · 2017 · Child s Nervous System
Paediatric Strategy Forum for medicinal product development of epigenetic modifiers for children: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
A. Pearson, K. Stegmaier, F. Bourdeaut, G. Reaman, D. Heenen, M. Meyers, S. Armstrong, P. Brown, D. D. De Carvalho, N. Jabado et al. · 2020 · European Journal of Cancer
Transcriptomic Analysis of Diffuse Intrinsic Pontine Glioma (DIPG) Identifies a Targetable ALDH-Positive Subset of Highly Tumorigenic Cancer Stem-like Cells
Rachel Kathleen Surowiec, Sarah F. Ferris, April Ann Apfelbaum, Carlos E. Espinoza, Ranjit Kumar Mehta, Karamoja Monchamp, Veerin R. Sirihorachai, Karan Bedi, Mats E. Ljungman, Stefanie Galbán · 2020 · Molecular Cancer Research
Histone H3.3 K27M chromatin functions implicate a network of neurodevelopmental factors including ASCL1 and NEUROD1 in DIPG
Nichole Lewis, Rachel Herndon Klein, Cailin Kelly, Jennifer Q. Yee, Paul S. Knoepfler · 2022 · Epigenetics & Chromatin
Oncohistones and disrupted development in pediatric-type diffuse high-grade glioma
Jennifer Karin Ocasio, Kaitlin M. Budd, Jordan T. Roach, Jared M. Andrews, Suzanne J. Baker · 2023 · Cancer and Metastasis Reviews
Patient-Derived Orthotopic Xenograft Models of Pediatric Brain Tumors: In a Mature Phase or Still in Its Infancy?
Eva Hermans, Esther Hulleman · 2020 · Frontiers in Oncology
Oncohistone Mutations in Diffuse Intrinsic Pontine Glioma
Xu Zhang, Zhiguo Zhang · 2019 · Trends in cancer
Targeting NAD+ Biosynthesis Overcomes Panobinostat and Bortezomib-Induced Malignant Glioma Resistance
Esther P. Jane, Daniel R. Premkumar, Swetha Thambireddy, Brian J. Golbourn, Sameer Agnihotri, Kelsey C. Bertrand, Stephen C. Mack, Max I. Myers, Ansuman Chattopadhyay, D. Lansing Taylor et al. · 2020 · Molecular Cancer Research
Oncohistone interactome profiling uncovers contrasting oncogenic mechanisms and identifies potential therapeutic targets in high grade glioma
Robert Siddaway, Laura Canty, Sanja Pajovic, Scott Milos, Étienne Coyaud, Stefanie-Grace Sbergio, Arun Kumaran Anguraj Vadivel, Evan Lubanszky, Hwa Young Yun, Alessia Portante et al. · 2022 · Acta Neuropathologica
Histone H3 K27M mutations in adult cerebellar high-grade gliomas
Satoshi Nakata, Sumihito Nobusawa, Tatsuya Yamazaki, Tadashi Osawa, Keishi Horiguchi, 橋場康弘, H. Yaoita, Nozomi Matsumura, Hayato Ikota, Junko Hirato et al. · 2017 · Brain Tumor Pathology
Precision Medicine in Pediatric Neurooncology: A Review
Aaron Y. Mochizuki, Isaura M. Frost, Melina B. Mastrodimos, Ashley Plant, Anthony Wang, Theodore Bruce Moore, Robert Michael Prins, Paul S. Weiss, Steven John Jonas · 2017 · ACS Chemical Neuroscience
18F-Radiolabeled Panobinostat Allows for Positron Emission Tomography Guided Delivery of a Histone Deacetylase Inhibitor
Harikrishna Kommidi, Umberto Tosi, Uday Bhanu Maachani, Hua Guo, Christopher S. Marnell, Benedict Law, Mark M. Souweidane, Richard Ting · 2018 · ACS Medicinal Chemistry Letters
The Integration of Biology Into the Treatment of Diffuse Intrinsic Pontine Glioma: A Review of the North American Clinical Trial Perspective
Jessica R. Clymer, Mark W. Kieran · 2018 · Frontiers in Oncology
Epigenetic reprogramming and chromatin accessibility in pediatric diffuse intrinsic pontine gliomas: a neural developmental disease
Flor Mendez, Felipe Javier Núñez, María Belén Garcia-Fabiani, Santiago Haase, Stephen V. Carney, Jessica C. Gauss, Oren Josh Becher, Pedro Ricardo Lowenstein, Maria Graciela Castro · 2019 · Neuro-Oncology
Convection-enhanced delivery for brain malignancies: Technical parameters, formulation strategies and clinical perspectives
Sara Jamshidi Parvar, Cheng In Wong, Andrew Lewis, Elwira Szychot, Christopher J. Morris, David Shorthouse, Karolina Dziemidowicz · 2025 · Advanced Drug Delivery Reviews
Repurposing the anti-epileptic drug sodium valproate as an adjuvant treatment for diffuse intrinsic pontine glioma
Clare L. Killick-Cole, William Singleton, Alison S. Bienemann, Daniel J. Asby, Marcella J. Wyatt, Lisa J. Boulter, Neil U. Barua, Steven Gill · 2017 · PLoS ONE
Exploiting 4-1BB immune checkpoint to enhance the efficacy of oncolytic virotherapy for diffuse intrinsic pontine gliomas
Virginia Laspidea, Montse Puigdelloses, Sara Labiano, Lucía Marrodán, Marc García-Moure, Marta Zalacaín, Marisol González-Huarriz, Naiara Martínez-Vélez, Iker Ausejo‐Mauleon, Daniel de la Nava et al. · 2022 · JCI Insight
Pioneering models of pediatric brain tumors
Florina Grigore, Serena Johanna Yang, Clark C. Chen, Tomoyuki Koga · 2023 · Neoplasia
Superenhancers as master gene regulators and novel therapeutic targets in brain tumors
Hai-Hui Zhuang, Qiang Qu, Xin-Qi Teng, Ying-Huan Dai, Jian Qu · 2023 · Experimental & Molecular Medicine
Brain‐Targeted Exosomes‐Based Drug Delivery System to Overcome the Treatment Bottleneck of Brainstem Glioma
Junge Chen, Shaobo Shan, Bozhang Xia, Liwei Zhang, Xing‐Jie Liang · 2023 · Advanced Functional Materials
Investigational new drugs for brain cancer
Verena Staedtke, Ren-Yuan Bai, John Laterra · 2016 · Expert Opinion on Investigational Drugs
CDK4/6 and PDGFRA Signaling as Therapeutic Targets in Diffuse Intrinsic Pontine Glioma
Christine M. Hoeman, Chen Shen, Oren Josh Becher · 2018 · Frontiers in Oncology
Serum metabolic profiling enables diagnosis, prognosis, and monitoring for brainstem gliomas
Keke Li, Ruimin Wang, Zhengying Gu, Wenyun Weng, Wanshan Liu, Yida Huang, Jiao Wu, Ziyue Zhang, Shouzhi Yang, Jun Su et al. · 2025 · Nature Communications
Histone deacetylases: A novel class of therapeutic targets for pancreatic cancer
Xue-Song Xiang, Pengcheng Li, Wenquan Wang, Liang Liu · 2022 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Risk stratification of H3 K27M–mutant diffuse midline gliomas based on anatomical locations: an integrated systematic review of individual participant data
Huy Gia Vuong, Hieu Trong Le, Andrew H. Jea, Rene Y. McNall‐Knapp, Ian F. Dunn · 2022 · Journal of Neurosurgery Pediatrics
Small Molecule Inhibitors in Adult High-Grade Glioma: From the Past to the Future
Wenda Huang, Zhaonian Hao, Feng Mao, Dongsheng Guo · 2022 · Frontiers in Oncology
Harmaline to Human Mitochondrial Caseinolytic Serine Protease Activation for Pediatric Diffuse Intrinsic Pontine Glioma Treatment
Morena Miciaccia, Francesca Rizzo, Antonella Centonze, Gianfranco Cavallaro, Marialessandra Contino, Domenico Armenise, Olga Maria Baldelli, Roberta Solidoro, Savina Ferorelli, Pasquale Scarcia et al. · 2024 · Pharmaceuticals
Panobinostat, a histone deacetylase inhibitor, suppresses leptomeningeal seeding in a medulloblastoma animal model
Ji Hoon Phi, Seung Ah Choi, Pil Ae Kwak, Ji Yeoun Lee, Kyu‐Chang Wang, Do Won Hwang, Seung‐Ki Kim · 2017 · Oncotarget
Identification of Novel RAS Signaling Therapeutic Vulnerabilities in Diffuse Intrinsic Pontine Gliomas
Robert F. Koncar, Brittany Dey, Ann-Catherine J. Stanton, Nishant Agrawal, Michelle Wassell, Lauren H. McCarl, Abigail L. Locke, Lauren Sanders, Olena M. Vaske, Max I. Myers et al. · 2019 · Cancer Research
Preclinical therapeutic targets in diffuse midline glioma
Michaël Hananja Meel, Gertjan J.L. Kaspers, Esther Hulleman · 2019 · Drug Resistance Updates
Histone-Mutant Glioma: Molecular Mechanisms, Preclinical Models, and Implications for Therapy
Maya Srikanth Graham, Ingo K. Mellinghoff · 2020 · International Journal of Molecular Sciences
Chemotherapy in pediatric brain tumor and the challenge of the blood–brain barrier
Malik Johid Reza, Anthony T. Podany, Parvez Κhan, Christopher L. Shaffer, Jawed Akhtar Siddiqui, Janina Baranowska‐Kortylewicz, Jennifer Lê, Courtney Vail Fletcher, Sadia Afruz Ether, Sean N. Avedissian · 2023 · Cancer Medicine
Multiparametric MRI-Based Radiomics Model for Predicting H3 K27M Mutant Status in Diffuse Midline Glioma: A Comparative Study Across Different Sequences and Machine Learning Techniques
Wei Guo, Dejun She, Zhen Xing, Xiang Lin, Feng Wang, Yang Sup Song, Dairong Cao · 2022 · Frontiers in Oncology
Interdisciplinary care of children with diffuse midline glioma
Christina Coleman, Katherine S. Chen, Alex Y. Lu, Elizabeth L. Seashore, Schuyler Stoller, Taron Davis, Steve E. Braunstein, Nalin M. Gupta, Sabine Mueller · 2022 · Neoplasia
Molecular alterations in pediatric brainstem gliomas
Mikaela Porkholm, Anna Raunio, Reetta Vainionpää, Tarja Salonen, Juha Antero Hernesniemi, Leena K. Valanne, Jarno Satopää, Atte Karppinen, Minna Oinas, Olli Tynninen et al. · 2017 · Pediatric Blood & Cancer
Gliomas in Children
Dominik Sturm, Mariella G. Filbin · 2018 · Seminars in Neurology